{
  "patientId": "HL001",
  "demographics": {
    "name": "Michael Rivera",
    "dob": "1998-08-15",
    "gender": "Male",
    "address": "12 River St, Metro City, USA",
    "phone": "555-0101",
    "insurance": "BlueCross BlueShield - Policy #BCBS-MR-202598",
    "referringPhysician": "Dr. Sarah Bell (Hematology/Oncology)",
    "emergencyContact": "Maria Rivera (Mother) - 555-0102",
    "advanceDirectives": "Full Code. On file, verified 03/18/2025.",
    "supportServices": "Referred to AYA (Adolescent and Young Adult) Oncology Support Group. Long-term survivorship care plan discussed and will be provided at end of treatment.",
    "mobility": "Independent, Ambulatory. ECOG Performance Status 0."
  },
  "diagnosis": {
    "primary": "Classic Hodgkin Lymphoma (CHL), Nodular Sclerosis type",
    "location": "Supradiaphragmatic Nodes (Neck/Chest)",
    "datePathologicDiagnosis": "01/10/2025 (Excisional biopsy, Left Cervical Node)",
    "sitesOfInvolvement": "Bilateral Cervical nodes (Level II, III), Bilateral Supraclavicular nodes, and Upper Anterior Mediastinal nodes. All disease is non-bulky (<10 cm).",
    "annArborStage": "Stage IIA",
    "riskGroup": "Favorable, Early-Stage (German Hodgkin Study Group - GHSG criteria: ESR <50, no large mediastinal mass, <3 nodal sites, Stage I/II without risk factors).",
    "symptomsAtPresentation": "Patient presented after noticing a persistent, painless lump in the left side of his neck while shaving. He denied any fever, night sweats, unintentional weight loss, or pruritus (No 'B' symptoms).",
    "pathologyFindings": [
      "Excisional Biopsy, Left Cervical Lymph Node (01/10/2025): Nodular Sclerosis Classic Hodgkin Lymphoma. The node is effaced by nodules of lymphohistiocytic cells separated by fibrous bands. Lacunar-type Reed-Sternberg cells are identified. Immunohistochemistry: Reed-Sternberg cells are CD30+, CD15+, PAX5 (weak)+, CD45-, CD20-."
    ],
    "relevantHistory": "Previously healthy 26-year-old male. He is a full-time graduate student. No significant past medical history. No family history of hematologic malignancies.",
    "baselineStatus": "Post-chemotherapy, ECOG 0. All palpable nodes have resolved. Patient feels well and is eager to complete therapy."
  },
  "treatmentPlan": {
    "radOnc": "Dr. Robert Jones",
    "medOnc": "Dr. Sarah Bell",
    "treatmentSite": "Involved Sites Neck/Supraclavicular/Mediastinum (Mantle Field)",
    "intent": "Curative",
    "modality": "Combined Modality Therapy: Abbreviated Chemotherapy followed by Involved Site Radiation Therapy (ISRT).",
    "totalDose": "20 Gy",
    "fractionation": "10 fx",
    "rtRxDetails": "20 Gy in 10 fractions (2.0 Gy/fx)",
    "targetVolumeSummary": "The Clinical Target Volume (CTV) is designed to encompass the initial, pre-chemotherapy sites of nodal involvement in the bilateral neck, supraclavicular fossae, and upper mediastinum, as defined by the baseline PET/CT. The Planning Target Volume (PTV) is a 1.0 cm expansion on the CTV.",
    "techniqueSummary": "3D-Conformal Radiation Therapy (3D-CRT) using opposed Anterior-Posterior/Posterior-Anterior (AP/PA) fields. This is a modern 'mini-mantle' field, shaped with multi-leaf collimators (MLCs) to shield critical organs like the lungs, heart, and larynx, which is a significant improvement over historical, large rectangular mantle fields.",
    "priorSystemicChemo": "2 cycles of ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine). Completed 03/15/2025. Interim PET/CT showed an excellent response (Deauville Score 2).",
    "medications": [
      "Magic Mouthwash (Lidocaine, Diphenhydramine, Maalox) - Swish and spit PRN for sore throat.",
      "Moisturizer (e.g., Eucerin) for neck skin PRN dryness.",
      "Acetaminophen PRN for throat discomfort."
    ],
    "therapistAlerts": [
      "Patient is immobilized in a thermoplastic mask. Ensure mask is indexed and fits well daily, with no pressure points.",
      "This is a 'mantle' type field. Ensure patient's chin is extended and clear of the superior border of the light field.",
      "Monitor daily for symptoms of sore throat (esophagitis) or difficulty swallowing. Report to RN/MD.",
      "Verify daily setup with kV imaging to spine. Pay close attention to the lung shielding provided by the MLCs."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "03/20/2025",
      "setupInstructions": "Supine with head in a neutral position. A custom thermoplastic mask covering the head and shoulders was fabricated for immobilization. Arms are down at sides. Patient instructed to breathe shallowly during scan.",
      "immobilization": "Aquaplast mask (Head and Shoulders type), indexed to couch.",
      "referenceMarks": "Reference tattoos placed on chest. Marks for daily alignment drawn on the mask and aligned to room lasers. Isocenter placed at the sternal angle.",
      "scanner": "Philips Big Bore CT",
      "sliceThickness": "2.5 mm",
      "contrastUsed": "IV Contrast administered to delineate vessels and nodal anatomy in the mediastinum.",
      "ctNotes": "CT acquired for ISRT planning. The scan was fused with the pre-chemotherapy diagnostic PET/CT for accurate target delineation of the involved nodal regions. Patient tolerated simulation well."
    },
    "dosimetry": {
      "planId": "MRHL001_ISRT_Mantle",
      "planStatus": "Final - Approved by Dr. Robert Jones (03/25/2025)",
      "rx": "20 Gy / 10 fx",
      "technique": "3D-CRT",
      "energy": "6MV",
      "numberOfFieldsOrArcs": 2,
      "gantryAngles": "0 (AP), 180 (PA)",
      "collAngles": "0",
      "couchAngles": "0",
      "isoCoords": "Mid-plane at sternal angle.",
      "tps": "RayStation v11",
      "algorithm": "Monte Carlo",
      "hetero": "Yes",
      "norm": "100% of dose prescribed to isocenter.",
      "constraints": {
        "Heart Mean": "< 5 Gy (achieved 4.1 Gy)",
        "Total Lung V20": "< 15% (achieved 12.5%)",
        "Spinal Cord Max": "< 20 Gy (achieved 18.9 Gy)",
        "Thyroid Gland Mean": "< 20 Gy (achieved 19.5 Gy)"
      },
      "planNotes": "Consolidative ISRT for favorable early-stage Hodgkin Lymphoma. AP/PA fields are shaped with MLCs to create a 'mini-mantle' field, covering involved neck, supraclavicular, and mediastinal nodes while shielding the majority of the lungs and heart.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "kV Imaging (Orthogonal Pair - AP & Lateral)",
        "alignment": "Primary match to vertebral bodies (C-spine and upper T-spine). Secondary check of lung apices and overall field shape.",
        "tolerances": "Translational: +/- 3mm"
      },
      "qaChecks": [
        { "date": "2025-03-25", "type": "Initial Chart Check", "by": "Physics Staff (AK)", "result": "Pass" },
        { "date": "2025-03-25", "type": "Physics Plan QA", "by": "Medical Physicist (SD)", "result": "Pass (MU calculation verification)" }
      ],
      "fieldDetails": [
        { "fieldName": "AP Mantle", "fieldSize": "24.0 cm x 20.0 cm", "gantryAngle": "0", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 115, "ssd": "89.0 cm" },
        { "fieldName": "PA Mantle", "fieldSize": "24.0 cm x 20.0 cm", "gantryAngle": "180", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 120, "ssd": "88.0 cm" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        { "fractionNumber": 1, "totalFractions": 10, "date": "2025-03-27", "machine": "LINAC2", "therapistInitials": "AM, LW", "setupVerification": "Tolerances Met", "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "None", "painAssessment": "0/10", "patientConcerns": "None.", "instructionsGiven": "Reinforced skin care instructions and to report any sore throat or difficulty swallowing.", "dailyNotes": "First treatment delivered. Patient tolerated the mask well. Physician approved initial kV images." },
        { "fractionNumber": 5, "totalFractions": 10, "date": "2025-04-02", "machine": "LINAC2", "therapistInitials": "AM, LW", "setupVerification": "Tolerances Met", "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "Mild sore throat (esophagitis Grade 1).", "painAssessment": "1/10", "patientConcerns": "Throat feels a little scratchy.", "instructionsGiven": "Recommended warm salt water gargles. Reminded that this is expected and should remain mild.", "dailyNotes": "OTV today with Dr. Jones. Setup is reproducible. Mild, expected esophagitis noted. Continue plan." },
        { "fractionNumber": 10, "totalFractions": 10, "date": "2025-04-09", "machine": "LINAC2", "therapistInitials": "AM, LW", "setupVerification": "Tolerances Met", "patientTolerance": "Good", "generalSideEffects": "Mild fatigue.", "siteSpecificSideEffects": "Sore throat persists but has not worsened (Grade 1). No skin reaction.", "painAssessment": "1/10", "patientConcerns": "Relieved to be finished.", "instructionsGiven": "Provided end-of-treatment instructions. Sore throat should resolve in 1-2 weeks. Explained long-term follow-up plan, including yearly thyroid checks.", "dailyNotes": "Final treatment delivered. Patient tolerated the entire course exceptionally well. Confirmed follow-up appointments with Med Onc and Rad Onc." }
      ]
    }
  },
  "imagingAndReports": [
    { "date": "01/10/2025", "type": "Pathology Report", "summary": "Nodular Sclerosis Classic Hodgkin Lymphoma from L Cervical Node Biopsy.", "reportDetails": { "accessionNumber": "S-25-1122", "specimenSource": "Excisional Biopsy, Left Level III Cervical Lymph Node", "diagnosis": "Nodular Sclerosis Classic Hodgkin Lymphoma (CHL)", "microscopicDescription": "The lymph node architecture is replaced by nodules of mixed inflammatory cells, separated by dense collagen bands. Within the nodules, characteristic Lacunar-type Reed-Sternberg cells are identified.", "immunohistochemistry": "The atypical cells are positive for CD30 and CD15, and negative for CD45 and CD20, confirming the diagnosis of CHL." } },
    { "date": "01/08/2025", "type": "FDG-PET/CT (Staging)", "summary": "FDG-avid nodes in neck, supraclavicular regions, and mediastinum. Deauville 5.", "reportDetails": { "accessionNumber": "PET-25-1088", "protocol": "Whole Body FDG-PET/CT", "findings": "Intensely FDG-avid lymphadenopathy is present in the bilateral cervical chains, bilateral supraclavicular fossae, and the prevascular and right paratracheal mediastinum. The largest node measures 2.5 cm. SUVmax in the left supraclavicular region is 14.5. No infradiaphragmatic or extranodal disease.", "impression": "Deauville Score 5. Hypermetabolic adenopathy consistent with Stage IIA Hodgkin Lymphoma." } },
    { "date": "03/10/2025", "type": "FDG-PET/CT (Interim)", "summary": "Excellent metabolic response. Residual uptake less than liver (Deauville 2).", "reportDetails": { "accessionNumber": "PET-25-4588", "protocol": "Whole Body FDG-PET/CT", "comparison": "PET/CT from 01/08/2025", "findings": "Marked interval decrease in size and FDG-avidity of all previously noted lymph nodes. There is faint residual uptake in the right supraclavicular region with an SUVmax of 1.8, which is below background liver uptake.", "impression": "Deauville Score 2: Excellent partial metabolic response, consistent with a complete response. Findings support de-escalation of therapy and proceeding with planned consolidative ISRT." } }
  ],
  "dicomImages": [
    { "description": "Staging PET/CT (01/08/2025)", "seriesType": "PT", "ohifViewerUrl": "" },
    { "description": "Interim PET/CT (03/10/2025)", "seriesType": "PT", "ohifViewerUrl": "" },
    { "description": "CT Simulation (03/20/2025)", "seriesType": "CT", "ohifViewerUrl": "" }
  ],
  "labResults": [
    { "date": "01/10/2025", "test": "CBC/CMP", "value": "WNL", "notes": "Baseline labs prior to chemotherapy." },
    { "date": "01/10/2025", "test": "ESR", "value": "25", "units": "mm/hr", "range": "<30", "notes": "Baseline Erythrocyte Sedimentation Rate, not elevated (favorable prognostic factor)." },
    { "date": "03/25/2025", "test": "CBC (Pre-RT)", "value": "WBC 6.8, Hgb 14.1, Plt 310k", "notes": "Counts have fully recovered from 2 cycles of ABVD." },
    { "date": "03/25/2025", "test": "TSH (Pre-RT)", "value": "1.8", "units": "mIU/L", "range": "0.4-4.0", "notes": "Baseline thyroid function prior to neck irradiation." }
  ],
  "progressNotes": [
    { "date": "01/12/2025", "author": "Dr. Sarah Bell (Med Onc)", "type": "Initial Consult", "summary": "26 y/o male with biopsy-proven Nodular Sclerosis CHL. Staging PET/CT confirms Stage IIA, non-bulky disease. Per GHSG criteria, this is favorable-risk. Discussed standard of care treatment: 2 cycles of ABVD followed by an interim PET scan. If the response is excellent (Deauville 1-3), he will proceed to 20 Gy of Involved Site Radiation Therapy (ISRT). Explained rationale, goals, and side effects. Patient is motivated and agrees to proceed." },
    { "date": "03/16/2025", "author": "Dr. Sarah Bell (Med Onc)", "type": "Post-Chemotherapy Visit", "summary": "Michael has completed 2 cycles of ABVD with excellent tolerance. The interim PET scan shows a Deauville 2 response, which is an excellent metabolic response. He is now ready for the consolidation radiation therapy phase. Have placed referral to Dr. Jones in Radiation Oncology." },
    { "date": "03/18/2025", "author": "Dr. Robert Jones (Rad Onc)", "type": "Initial Consult", "summary": "Patient is a pleasant 26 y/o male with Stage IIA favorable CHL, s/p ABVDx2 with a Deauville 2 response. I have reviewed all imaging. The plan is for consolidative ISRT to the pre-chemotherapy involved sites in the neck, supraclavicular, and mediastinal regions. Dose will be 20 Gy in 10 fractions. We discussed the modern 'mini-mantle' technique to minimize dose to heart and lungs, the procedure, and potential side effects (fatigue, sore throat, skin redness, and long-term risk of hypothyroidism). Patient understands and wishes to proceed. CT simulation scheduled." },
    { "date": "04/09/2025", "author": "Dr. Robert Jones (Rad Onc)", "type": "End of Treatment Note", "summary": "Michael has completed his planned course of 20 Gy ISRT. He tolerated the treatment exceptionally well, with only Grade 1 esophagitis and no significant fatigue or skin reaction. He is now finished with all planned therapy. He will follow up with Dr. Bell for long-term surveillance. Long-term risks (thyroid, cardiac) were reviewed again, and the importance of lifelong health maintenance was stressed." }
  ],
  "patientEducation": {
    "goalsDiscussed": "To deliver consolidation radiation therapy following an excellent response to chemotherapy. This is a standard and critical part of the curative treatment for favorable, early-stage Hodgkin Lymphoma, designed to maximize the chance of a durable cure.",
    "sideEffectsReviewed": "Acute: The most likely side effects are fatigue and a sore throat (esophagitis) from radiation to the chest and neck. There may be mild skin redness in the treated area. Taste changes are possible but usually mild and temporary. Late: We discussed the small but real long-term risks, including hypothyroidism (requiring annual blood tests for life), a slightly increased risk of heart disease, and a very small risk of secondary cancers in the future. Modern radiation techniques (ISRT) are designed specifically to minimize these risks.",
    "safetyConsiderations": "Good oral hygiene during treatment. Using moisturizers on the neck if skin becomes dry. Reporting any severe sore throat, difficulty swallowing, or new cough/shortness of breath to the team.",
    "patientResponsibilities": "Attend all daily treatments. Report symptoms to the team. Adhere to long-term follow-up recommendations, especially annual thyroid function tests.",
    "medicationCompliance": "Use prescribed mouthwash or topical creams as needed for symptom relief."
  },
  "scheduling": [
    { "date": "01/10/2025", "type": "Excisional Biopsy", "location": "Outpatient Surgery Center", "status": "Completed" },
    { "date": "01/12/2025", "type": "Medical Oncology Consult", "location": "Oncology Clinic", "status": "Completed" },
    { "date": "Jan-Mar 2025", "type": "Chemotherapy (ABVD x 2)", "location": "Infusion Center", "status": "Completed" },
    { "date": "03/10/2025", "type": "Interim PET/CT Scan", "location": "Radiology Department", "status": "Completed" },
    { "date": "03/18/2025", "type": "Radiation Oncology Consult", "location": "Rad Onc Clinic", "status": "Completed" },
    { "date": "03/20/2025", "type": "CT Simulation", "location": "Rad Onc Sim Suite", "status": "Completed" },
    { "date": "03/27/2025", "type": "RT Start (Fx 1/10)", "location": "LINAC 2", "status": "Completed" },
    { "date": "04/09/2025", "type": "RT End (Fx 10/10)", "location": "LINAC 2", "status": "Completed" },
    { "date": "05/09/2025", "type": "1-Month Post-RT Follow-up", "location": "Rad Onc Clinic", "status": "Scheduled" },
    { "date": "07/09/2025", "type": "3-Month Post-Treatment PET/CT", "location": "Radiology Department", "status": "Scheduled" }
  ],
  "cptCharges": [
    { "code": "77290", "description": "Simulation, Complex (3D)", "frequency": "Once" },
    { "code": "77334", "description": "Treatment device, Complex (Aquaplast mask)", "frequency": "Once" },
    { "code": "77295", "description": "3D radiotherapy plan, specifies fields and blocks", "frequency": "Once" },
    { "code": "77300", "description": "Basic radiation dosimetry calculation", "frequency": "Per plan" },
    { "code": "77412", "description": "Radiation treatment delivery, complex (AP/PA with MLC shaping)", "frequency": "10" },
    { "code": "77387", "description": "Image Guided RT (IGRT - Daily kV imaging)", "frequency": "10" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "2" }
  ],
  "diagnosisSearch": "Hodgkin Lymphoma, Mantle, Supradiaphragmatic, ISRT"
}
